Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E P M Corssmit

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
American Journal of Medical Genetics. Part A|October 14, 2005
Kallmann syndrome in a 47,XXX patientE P M Corssmit, S B Seminara, N Pitteloud, et al.
Journal of Endocrinological Investigation|March 14, 2021
Interleukin-6 producing pheochromocytoma/paraganglioma: case series from a tertiary referral centre for pheochromocytomas and paragangliomasA C Meijs, M A Schroijen, M Snel, et al.
Clinical Endocrinology|October 15, 2013
(131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysisL T van Hulsteijn, N D Niemeijer, O M Dekkers, et al.
Clinical Endocrinology|July 22, 2014
Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysisN D Niemeijer, G Alblas, L T van Hulsteijn, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2013
Avoiding and nonexpressing: coping styles of patients with paragangliomasL T van Hulsteijn, A A Kaptein, A Louisse, et al.
Journal of Medical Genetics|October 27, 2012
Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysisLeonie Theresia van Hulsteijn, Olaf M Dekkers, Frederik J Hes, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 18, 2008
Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imagingB Havekes, E W Lai, E P M Corssmit, et al.
Journal of Neuroendocrinology|November 2, 2006
Gut-brain axis: regulation of glucose metabolismA C Heijboer, H Pijl, A M Van den Hoek, et al.
European Journal of Endocrinology|July 9, 2013
Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolitesN van Duinen, E P M Corssmit, W H A de Jong, et al.
The Netherlands Journal of Medicine|March 25, 2009
Evaluation of Endocrine Tests. C: glucagon and clonidine test in phaeochromocytomaP H Bisschop, E P M Corssmit, S J Baas, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
American Journal of Medical Genetics. Part A|October 14, 2005
Kallmann syndrome in a 47,XXX patientE P M Corssmit, S B Seminara, N Pitteloud, et al.
Journal of Endocrinological Investigation|March 14, 2021
Interleukin-6 producing pheochromocytoma/paraganglioma: case series from a tertiary referral centre for pheochromocytomas and paragangliomasA C Meijs, M A Schroijen, M Snel, et al.
Clinical Endocrinology|October 15, 2013
(131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysisL T van Hulsteijn, N D Niemeijer, O M Dekkers, et al.
Clinical Endocrinology|July 22, 2014
Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysisN D Niemeijer, G Alblas, L T van Hulsteijn, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2013
Avoiding and nonexpressing: coping styles of patients with paragangliomasL T van Hulsteijn, A A Kaptein, A Louisse, et al.
Journal of Medical Genetics|October 27, 2012
Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysisLeonie Theresia van Hulsteijn, Olaf M Dekkers, Frederik J Hes, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 18, 2008
Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imagingB Havekes, E W Lai, E P M Corssmit, et al.
Journal of Neuroendocrinology|November 2, 2006
Gut-brain axis: regulation of glucose metabolismA C Heijboer, H Pijl, A M Van den Hoek, et al.
European Journal of Endocrinology|July 9, 2013
Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolitesN van Duinen, E P M Corssmit, W H A de Jong, et al.
The Netherlands Journal of Medicine|March 25, 2009
Evaluation of Endocrine Tests. C: glucagon and clonidine test in phaeochromocytomaP H Bisschop, E P M Corssmit, S J Baas, et al.
Pageof 5